Cyklokapron Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

cyklokapron

pfizer new zealand limited - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - active: tranexamic acid 100 mg/ml excipient: water for injection - haemorrhage or risk of haemorrhage in increased fibrinolysis or fibrinogenolysis. local fibrinolysis may occur in the following conditions: · prostatectomy and bladder surgery · menorrhagia · epistaxis · conisation of the cervix · management of dental extraction in patients with coagulopathies · ulcerative colitis · haematuria · gastrointestinal haemorrhage. general fibrinolysis as in prostatic and pancreatic cancer; after thoracic and other major surgery: · in obstetrical complications such as abruptio placentae and post-partum haemorrhage · in leukaemia and liver diseases and in connection with thrombolytic therapy with streptokinase.

Cyklokapron 100 mg/ml inj. sol. i.v. amp. Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cyklokapron 100 mg/ml inj. sol. i.v. amp.

pfizer sa-nv - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - tranexamic acid 100 mg/ml - tranexamic acid

Cyklokapron 100 mg/mL solution for injection/infusion Irlanda - anglès - HPRA (Health Products Regulatory Authority)

cyklokapron 100 mg/ml solution for injection/infusion

pfizer healthcare ireland - tranexamic acid - solution for injection/infusion - 100 milligram(s)/millilitre - amino acids; tranexamic acid

CYKLOKAPRON INJECTION 100 mgml Singapur - anglès - HSA (Health Sciences Authority)

cyklokapron injection 100 mgml

pfizer private limited - tranexamic acid - injection - 100 mg/ml - tranexamic acid 100 mg/ml

Cyklokapron 100 mg/ml inj. sol. i.v. amp. Bèlgica - anglès - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

cyklokapron 100 mg/ml inj. sol. i.v. amp.

pfizer sa-nv - tranexamic acid 100 mg/ml - solution for injection - 100 mg/ml - tranexamic acid 500 mg - tranexamic acid

CYKLOKAPRON 100 MG/ML SOLUTION Canadà - anglès - Health Canada

cyklokapron 100 mg/ml solution

pfizer canada ulc - tranexamic acid - solution - 100mg - tranexamic acid 100mg - hemostatics

CYKLOKAPRON INJ 100MG-ML INJECTION Solution for injection Aràbia Saudita - anglès - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

cyklokapron inj 100mg-ml injection solution for injection

pfizer manufacturing belgium n.v., belgium - tranexamic acid - solution for injection - 100 mg/ml

Cyklokapron 500mg/5ml solution for injection ampoules Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

cyklokapron 500mg/5ml solution for injection ampoules

pfizer ltd - tranexamic acid - solution for injection - 100mg/1ml

Cyklokapron 100 mg/mL solution for injection/infusion Malta - anglès - Medicines Authority

cyklokapron 100 mg/ml solution for injection/infusion

pfizer hellas s.a. 243 messoghion ave., neo psychiko 15451, athens, greece - tranexamic acid - solution for injection/infusion - tranexamic acid 500 mg/5ml - antihemorrhagics

TRANEXAMIC ACID LUMACINA tranexamic acid 1000 mg/10 mL solution for injection ampoule Austràlia - anglès - Department of Health (Therapeutic Goods Administration)

tranexamic acid lumacina tranexamic acid 1000 mg/10 ml solution for injection ampoule

bridgewest perth pharma pty ltd - tranexamic acid, quantity: 1000 mg - injection, solution - excipient ingredients: water for injections - intravenous administration,adults,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery or total knee arthroplasty or total hip arthroplasty.,paediatrics,for the reduction of peri- and post-operative blood loss and the need for blood transfusion in patients undergoing cardiac surgery.